Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd. on March 7, 2024. Post the acquisition, Guiyang Xintian will hold 100% in Shanghai Huilun Biotechnology.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.63 CNY | +1.66% | +4.12% | -6.66% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.66% | 370M | |
+3.92% | 69.85B | |
+11.77% | 8.98B | |
-14.44% | 4.89B | |
+41.60% | 4.44B | |
+5.96% | 3.95B | |
+22.70% | 2.49B | |
-19.32% | 2.4B | |
-27.04% | 2.28B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.